Yamauchi P, Chen C-C, Ding Y, al. et. Secukinumab Is Associated With Improvements in Real-World Effectiveness Outcomes Through 12 Months of Follow-Up in Patients With Plaque Psoriasis: Analysis of US Dermatology Electronic Medical Records. J of Skin [Internet]. 2019Mar.11 [cited 2024Jul.3];3(2):173. Available from: https://jofskin.org/index.php/skin/article/view/530